These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 3857219

  • 1. Epirubicin in colorectal cancer. A phase II study of the early clinical trials group (EORTC).
    Holdener EE, Hansen HH, Høst H, Bruntsch U, Cavalli F, Renard J, Pinedo HM, Rozencweig M.
    Invest New Drugs; 1985; 3(1):63-6. PubMed ID: 3857219
    [Abstract] [Full Text] [Related]

  • 2. Phase II evaluation of 4'-epi-doxorubicin in patients with advanced colorectal carcinoma.
    Michaelson R, Kemeny N, Young C.
    Cancer Treat Rep; 1982 Sep; 66(9):1757-8. PubMed ID: 6956441
    [Abstract] [Full Text] [Related]

  • 3. Phase II trial of 4'-epi-doxorubicin in metastatic colorectal carcinoma.
    Wils JA.
    Invest New Drugs; 1984 Sep; 2(4):397-9. PubMed ID: 6595243
    [Abstract] [Full Text] [Related]

  • 4. Phase II evaluation of 4'epi-doxorubicin in patients with metastatic colorectal carcinoma.
    Ferrazzi E, Pappagallo GL, Nicoletto O, Fornasiero A, Refatti F, Cartei G, Vinante O, Fiorentino MV.
    Tumori; 1984 Jun 30; 70(3):297-300. PubMed ID: 6588671
    [Abstract] [Full Text] [Related]

  • 5. A phase-II clinical trial of 4'-epi-doxorubicin in advanced solid tumors.
    Martoni A, Giovannini M, Tomasi L, Camaggi CM, Bellanova B, Monetti N, Rossini G, Tarquinii M, Martini A, Pannuti F.
    Cancer Chemother Pharmacol; 1984 Jun 30; 12(3):179-82. PubMed ID: 6584236
    [Abstract] [Full Text] [Related]

  • 6. [A phase I trial of 4'-epiadriamycin].
    Ogawa M, Ikeda K, Inagaki J, Horikoshi N, Inoue K, Nakada K, Usui N, Okada Y, Adachi K, Tada A.
    Gan To Kagaku Ryoho; 1984 Apr 30; 11(4):926-9. PubMed ID: 6586111
    [Abstract] [Full Text] [Related]

  • 7. [Phase II study of epirubicin on breast cancer: a cooperative group study].
    Tominaga T, Kitamura M, Nomura Y, Abe O, Enomoto K, Ikeda T, Izuo M, Iino Y, Taguchi T, Tamura K.
    Gan To Kagaku Ryoho; 1986 Jun 30; 13(6):2187-92. PubMed ID: 3459397
    [Abstract] [Full Text] [Related]

  • 8. Phase II trial of acivicin in patients with advanced colorectal carcinoma.
    Adolphson CC, Ajani JA, Stroehlein JR, Barlogie B, Bodey GP, Korinek J, Bedikian AY.
    Am J Clin Oncol; 1986 Jun 30; 9(3):189-91. PubMed ID: 3728371
    [Abstract] [Full Text] [Related]

  • 9. Phase II trial of epirubicin in advanced squamous, adeno- and large cell carcinoma of the lung.
    Joss RA, Hansen HH, Hansen M, Renard J, Rozencweig M.
    Eur J Cancer Clin Oncol; 1984 Apr 30; 20(4):495-9. PubMed ID: 6327315
    [Abstract] [Full Text] [Related]

  • 10. Phase II study of epirubicin in advanced malignant melanoma.
    Lopez M, Perno CF, Papaldo P, Di Lauro L, Ganzina F, Barduagni A.
    Invest New Drugs; 1984 Apr 30; 2(3):315-7. PubMed ID: 6595241
    [Abstract] [Full Text] [Related]

  • 11. Phase II study of a 21-day continuous infusion schedule with epirubicin in metastatic colorectal cancer.
    Greidanus J, Willemse PH, Sleijfer DT, Mulder NH, Verschueren RC, Nieweg R, de Vries EG.
    Eur J Cancer Clin Oncol; 1988 Apr 30; 24(4):801-2. PubMed ID: 3164271
    [No Abstract] [Full Text] [Related]

  • 12. [Phase II study of epirubicin on gastric cancer--a cooperative study of the Tokai Cancer Chemotherapy Group].
    Kimura K, Suga S, Kano H, Sakakibara K, Hayashi T, Nakai T, Nagano I, Yokoyama Y, Morise K, Hayakawa M.
    Gan To Kagaku Ryoho; 1986 Jul 30; 13(7):2440-5. PubMed ID: 3460530
    [Abstract] [Full Text] [Related]

  • 13. Phase II trial of esorubicin in patients with advanced colorectal carcinoma.
    Fiore J, Kemeny N, Raymond V, Young C.
    Cancer Treat Rep; 1986 Oct 30; 70(10):1241-2. PubMed ID: 3530453
    [No Abstract] [Full Text] [Related]

  • 14. Phase II evaluation of 4'-epi-doxorubicin in patients with metastatic colorectal carcinoma.
    Ajani JA, Kanojia MD, Bodey GP.
    Cancer Treat Rep; 1984 Dec 30; 68(12):1507-8. PubMed ID: 6595058
    [No Abstract] [Full Text] [Related]

  • 15. Epirubicin: a review of the pharmacology, clinical activity, and adverse effects of an adriamycin analogue.
    Cersosimo RJ, Hong WK.
    J Clin Oncol; 1986 Mar 30; 4(3):425-39. PubMed ID: 3005521
    [Abstract] [Full Text] [Related]

  • 16. Use of dexrazoxane as a cardioprotectant in patients receiving doxorubicin or epirubicin chemotherapy for the treatment of cancer. The Provincial Systemic Treatment Disease Site Group.
    Seymour L, Bramwell V, Moran LA.
    Cancer Prev Control; 1999 Apr 30; 3(2):145-59. PubMed ID: 10474762
    [Abstract] [Full Text] [Related]

  • 17. [Phase II study of epirubicin in inoperable or recurrent gastric cancer].
    Sakata Y, Yoshida Y.
    Gan To Kagaku Ryoho; 1986 May 30; 13(5):1887-92. PubMed ID: 3458431
    [Abstract] [Full Text] [Related]

  • 18. Phase II trial of 4'-epi-doxorubicin in advanced colorectal carcinoma: a Northern California Oncology Group study.
    Meyers FJ, Lewis B, Mitchell E, William L, Hannigan JF, Gribble M, Torti FM.
    Cancer Treat Rep; 1985 Jan 30; 69(1):143-4. PubMed ID: 3855385
    [No Abstract] [Full Text] [Related]

  • 19. Phase II study of acivicin in colorectal carcinoma: a National Cancer Institute of Canada study.
    Maroun JA, Fields AL, Pater JL, Stewart DJ, Cripps C, Eisenhauer E.
    Cancer Treat Rep; 1984 Sep 30; 68(9):1121-3. PubMed ID: 6478451
    [Abstract] [Full Text] [Related]

  • 20. A prospective randomized comparison of epirubicin and doxorubicin in patients with advanced breast cancer.
    Jain KK, Casper ES, Geller NL, Hakes TB, Kaufman RJ, Currie V, Schwartz W, Cassidy C, Petroni GR, Young CW.
    J Clin Oncol; 1985 Jun 30; 3(6):818-26. PubMed ID: 3859587
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.